Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Platelet Aggregation Devices Market Poised To Hit $2.94 Billion By 2030 With A 22.5% CAGR#_x000D_
The platelet aggregation devices market has experienced substantial growth in recent years. It is projected to expand from $1.04 billion in 2025 to $1.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 25.4%. This historical expansion can be linked to factors such as an increase in cardiovascular disease prevalence, the expansion of clinical diagnostic laboratories, a rise in the application of antiplatelet therapies, growing requirements for coagulation testing, and developments in hematology diagnostics._x000D_
_x000D_
The platelet aggregation devices market size is expected to experience significant growth in the coming years. It is projected to reach $2.94 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 22.5%. This anticipated growth is driven by factors such as the increasing adoption of personalized medicine, rising investments in advanced diagnostics, a growing demand for rapid platelet function testing, an expansion of research into blood disorders, and continuous innovation in diagnostic technologies. Noteworthy trends during the forecast period include the increasing use of automated platelet function analyzers, a surging demand for high-throughput testing systems, the rising integration of digital data management, the expansion of multi-channel aggregation devices, and an enhanced focus on diagnostic accuracy._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Platelet Aggregation Devices Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The rising occurrence of target diseases is projected to propel the platelet aggregation devices market in the coming years. Target diseases refer to specific health conditions that receive focused attention for prevention, diagnosis, and treatment due to their considerable impact on public health, encompassing conditions such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices assist in reducing the prevalence of these target diseases by facilitating prompt detection and efficient management of thrombotic risks, thus averting severe health events like heart attacks and strokes in at-risk groups. For example, in February 2024, data released by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), revealed that globally, there were approximately 20 million new cancer cases and 9.7 million deaths in 2022, with forecasts predicting a 77% increase, leading to more than 35 million new cases by 2050; lung cancer emerged as the most widespread worldwide with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Consequently, the growing incidence of target diseases is fueling the expansion of the platelet aggregation devices market._x000D_
_x000D_
#Platelet Aggregation Devices Market Segment Breakdown: Which Categories Lead On Revenue?#_x000D_
The platelet aggregation devices market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Reagents, Systems, Consumables And Accessories _x000D_
2) By Channel Configuration: Four Channel, Dual Channel, Eight Channel _x000D_
3) By Technology: Optical, Impedance, Other Technologies _x000D_
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Other Applications _x000D_
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users _x000D_
_x000D_
Subsegments:_x000D_
1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents_x000D_
2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems_x000D_
3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits_x000D_
_x000D_
#Platelet Aggregation Devices Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Key companies within the platelet aggregation devices market are intensifying their efforts to develop advanced solutions, introducing innovative products like the inaugural platelet pooling set intended to stabilize the U.S. platelet supply and address increasing requirements. Specifically, a platelet pooling set represents a specialized medical instrument utilized in plateletpheresis to gather and consolidate platelets from multiple donors into a singular unit for transfusion therapy. As an illustration, in February 2023, Terumo BCT Inc., a US-based provider of blood components and cellular technology, reported that the Food and Drug Administration (FDA), a US-based federal agency, had granted approval for its IMUGARD WB Platelet Pooling Set. The product offers an extended shelf life for platelets, secured FDA clearance for seven-day storage, and facilitates platelet recoupment from whole blood donations, thereby bolstering flexibility and overall availability in the platelet aggregation devices market. This introduction signifies a notable technological leap, addressing the imperative for enhanced platelet availability, more streamlined supply management, and bolstering the strained U.S. platelet supply to fulfill escalating demand in crucial medical interventions such as chemotherapy and organ transplants._x000D_
_x000D_
#Platelet Aggregation Devices Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG And Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago, Instrumentation Laboratory _x000D_
_x000D_
#View The Full Platelet Aggregation Devices Market Report:#_x000D_
_x000D_
#Platelet Aggregation Devices Market Regional Breakdown: Where Is Demand Concentrated?#_x000D_
North America was the largest region in the platelet aggregation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.